New developments in the management of narcolepsy
Vivien C Abad, Christian Guilleminault Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine, Stanford University Outpatient Center, Redwood City, CA, USA Abstract: Narcolepsy is a life-long, underrecognized sleep disorder that affects 0.02%–0.18% of the US...
Enregistré dans:
Auteurs principaux: | Abad VC, Guilleminault C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b15a6738adbc4be08828fb343f6c8a93 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment paradigms for cataplexy in narcolepsy: past, present, and future
par: Swick TJ
Publié: (2015) -
Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns
par: Barker EC, et autres
Publié: (2020) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
par: Vellieux G, et autres
Publié: (2021) -
Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
par: Guevarra JT, et autres
Publié: (2020) -
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
par: Calik MW
Publié: (2017)